Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Melanoma/Skin Cancer
Would you offer radiation therapy post lumpectomy for a small melanoma oligometastasis with negative margins?
If so, would you favor 30 Gy/5 fraction accelerated partial breast irradiation?
Answer from: Radiation Oncologist at Community Practice
I don’t know if RT will have benefits for melanoma with negative margins.
Sign in or Register to read more
Answer from: Radiation Oncologist at Academic Institution
Agree with Dr. @Beriwal, with oligomet with negative margins, I would watch.
Comments
Medical Oncologist at University of Virginia
Consider adjuvant systemic therapy for completely ...
7990
Sign in or Register to read more
15569
15573
Related Questions
Does radiation therapy (ex. to the breast) in patients with CDK4 mutations increase the risk of developing melanoma?
Would you consider adjuvant radiation for a patient with recurrent pelvic node melanoma s/p immunotherapy and pelvic lymph node dissection with complete pathological response (only necrotic tissue; no viable melanoma)?
When do you recommend SRT, if ever, for small SCCs and BCCs?
How would you manage a large area of multiple, recurrent cutaneous squamous cell carcinomas of the scalp with ulcerations and non-healing areas despite cryotherapy, multiple Mohs procedures, and 5-FU?
What are the indications for postoperative radiation for extramammary Paget's disease?
Do you obtain MRI for cutaneous SCC with microscopic PNI to assess for gross perineural tumor spread?
How would you manage a cardiac metastasis from Merkel cell carcinoma?
How would you palliate a large, symptomatic vaginal melanoma recurrence with limited small pelvic lymph node metastases?
How would you treat locally advanced melanoma of the scalp with several in transit lesions and a metastatic lesion to the parotid if the patient is progressing on immunotherapy such as pembrolizumab?
In patients with multiple basal cell carcinoma lesions on vismodegib, would you hold vismodegib while delivering radiation therapy to one locally advanced BCC lesion that was not amenable to surgery?